GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the human rxr alpha ligand binding domain bound to the synthetic agonist compound bms 649 and a coactivator peptide

Analyse Crystal structure of the human rxr alpha ligand binding domain bound to the… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1MVC
Type
protein
Length
223 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Rxr retinoid X receptor; Nuclear receptor coactivator 2
UniProt
P19793, Q15596
Ligands
BM6
Pockets
2 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 70% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARxr retinoid X receptorprotein21270% helix, 3% strandP19793
BNuclear receptor coactivator 2protein1164% helix, 0% strandQ15596

Ligands and binding sites

  • BM6 · 4-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-[1,3]dioxolan-2-yl]-benzoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13130.830.9340BM6
21020.390.7525empty

Interfaces

1 interface between chains.

  • A–B · 613 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 1MVC · Crystal structure of the human RXR alpha ligand binding domain bound to the synthetic… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.